JonesTrading analyst Soumit Roy initiated coverage with a Buy rating on Curis (CRIS – Research Report) today and set a
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that the first patient has been dosed in its Phas
Curis, Inc. (NASDAQ:CRIS)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $1.17 and traded as high as $1.22. Curis shares
Hyundai adopta la industria blockchain y de criptomonedas con tres registros de marcas. Hyundai estaría buscando lanzar un ecosistema blockchain a través de su filial con sede en Europa, Hdac, y el

Curis (NASDAQ:CRIS) Shares Gap Up to $1.36

06:04am, Friday, 26'th Jun 2020
Curis, Inc. (NASDAQ:CRIS) shares gapped up before the market opened on Wednesday . The stock had previously closed at $1.44, but opened at $1.36. Curis shares last traded at $1.26, with a volume of 16
Auditing firm CertiK is working with Hdac to record Internet of Things devices on a blockchain.
JonesTrading analyst Soumit Roy initiated coverage with a Buy rating on Curis (CRIS – Research Report) today and set a

The Only Way To Play Curis (NASDAQ:CRIS)

04:50pm, Friday, 12'th Jun 2020
Curis will continue to flounder even with its recent temporary surge in share price. Challenges, as the company stands, look insurmountable. At the end of March

8-K: CURIS INC

04:47am, Friday, 12'th Jun 2020
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange...
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced that it has entered into definitive agreements wi
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE